CHICAGO CAPITAL MANAGEMENT LLC
Q2 2026 Form 13-F
CHICAGO, ILLINOIS
CIK 0001580162
· CRD 175453
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q1 2015
$112.3M Reported Value Total
CHICAGO CAPITAL MANAGEMENT, LLC reports 6 total accounts under management (AUM). There are 6 discretionary accounts valued at $202,818,473, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
5 funds
· $359.4M gross asset value
Hedge Fund: $359.4M
Source: Form ADV filed 2026-03-27
Reported value
$112.3M
Quarter over quarter
+5.7%
Holdings
14
Top-10 concentration
65.7%
Filing Structure
Reports holdings for
- PRELUDE CAPITAL MANAGEMENT LLC · File #028-12257 · since Q1 2015 · declared by one filing
Key People
Form ADV owners & control persons
Steven Robert Gerbel
FOUNDER AND CIO
Ali Aziz
CHIEF FINANCIAL OFFICER & CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | July 22, 2026 |
| Form | 13F-HR |
| Reported value | $112.3M |
| Positions | 14 |
| Change in reported value | -7.0% |
| New positions | 14 |
| Exited positions | 16 |
| Position turnover | 100.0% |
| Top-10 concentration | 65.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Oct 21, 2026
|
10 | $110.4M |
|
Q2 2026 13F
Filed Jul 22, 2026
|
14 | $112.3M |
|
Q1 2026 13F
Filed Apr 27, 2026
|
13 | $120.7M |
|
Q4 2025 13F
Filed Feb 2, 2026
|
19 | $146.9M |
|
Q3 2025 13F
Filed Nov 7, 2025
|
7 | $111.8M |
|
Q2 2025 13F
Filed Aug 7, 2025
|
15 | $136.1M |
|
Q1 2025 13F
Filed May 9, 2025
|
15 | $160.9M |
|
Q4 2024 13F
Filed Feb 12, 2025
|
16 | $162.0M |
|
Q3 2024 13F
Filed Nov 8, 2024
|
10 | $149.6M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
12 | $129.3M |
|
Q1 2024 13F
Filed May 9, 2024
|
15 | $95.0M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
18 | $63.0M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
15 | $37.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
14 | $78.1M |
|
Q1 2023 13F
Filed May 11, 2023
|
21 | $91.1M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
22 | $110.2M |
|
Q3 2022 13F
Filed Nov 9, 2022
|
30 | $183.8M |
|
Q2 2022 13F
Filed Jul 27, 2022
|
28 | $176.2M |
|
Q1 2022 13F
Filed May 11, 2022
|
31 | $175.3M |
|
Q4 2021 13F
Filed Jan 28, 2022
|
27 | $144.8M |
27 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | NUVL NUVALENT INC | $11.1M | 9.84% |
| 2 | APGE APOGEE THERAPEUTICS INC | $9.8M | 8.73% |
| 3 | GTLS CHART INDS INC | $8.4M | 7.44% |
| 4 | BAND 0.5 04/01/28 BANDWIDTH INC | $7.6M | 6.79% |
| 5 | TMHC TAYLOR MORRISON HOME CORP | $7.2M | 6.39% |
| 6 | SABHLD 7.32 08/01/26 SABRE GLBL INC | $7.1M | 6.34% |
| 7 | RPD 0.25 03/15/27 RAPID7 INC | $6.3M | 5.62% |
| 8 | MGPI 1.875 11/15/41 MGP INGREDIENTS INC NEW | $5.9M | 5.28% |
| 9 | VERI 1.75 11/15/26 VERITONE INC | $5.4M | 4.8% |
| 10 | AMPH 2 03/15/29 AMPHASTAR PHARMACEUTICALS IN | $5.0M | 4.43% |
| 11 | REAL 1 03/01/28 THE REALREAL INC | $4.8M | 4.26% |
| 12 | FIVN 1 03/15/29 FIVE9 INC | $4.5M | 3.99% |
| 13 | SHAK 0 03/01/28 SHAKE SHACK INC | $4.0M | 3.53% |
| 14 | ETSY 0.25 06/15/28 ETSY INC | $3.9M | 3.5% |
| 15 | HPEPRC HEWLETT PACKARD ENTERPRISE C | $3.8M | 3.39% |
| 16 | SRPT 1.25 09/15/27 SAREPTA THERAPEUTICS INC | $3.0M | 2.67% |
| 17 | CPRX CATALYST PHARMACEUTICALS INC | $2.9M | 2.61% |
| 18 | ALOT ASTRONOVA INC | $2.8M | 2.54% |
| 19 | ESPR ESPERION THERAPEUTICS INC NE | $2.6M | 2.32% |
| 20 | TECH BIO-TECHNE CORP | $2.0M | 1.8% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.